Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $117 Million
  • Q4 2024

Birchview Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $117 Million distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $38.8M, Biodesix Inc with a value of $8.37M, Acadia Pharmaceuticals Inc with a value of $6.21M, Prothena Corp Public LTD CO with a value of $4.22M, and Neurocrine Biosciences Inc with a value of $4.13M.

Examining the 13F form we can see an increase of $8.74M in the current position value, from $108M to 117M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $117 Million
Healthcare: $112 Million
Energy: $3.71 Million
ETFs: $1.63 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$127B
$38.8 Million 33.08% of portfolio
685,182
Q4 2024 Reduced 0.15%
$31.6M
$8.37 Million 7.15% of portfolio
5,581,176
Q4 2024 Added 0.72%
$3.17B
$6.21 Million 5.3% of portfolio
338,400
Q4 2024 Reduced 15.48%
$742M
$4.22 Million 3.6% of portfolio
304,574
Q4 2024 Added 45.33%
$11.4B
$4.13 Million 3.52% of portfolio
30,240
Q3 2024 Reduced 28.41%
$6.49B
$3.73 Million 3.18% of portfolio
74,000
Q2 2024 Added 48.0%
$14.6B
$3.53 Million 3.01% of portfolio
10,000
Q2 2024 Reduced 9.09%
$312M
$3.24 Million 2.77% of portfolio
764,062
Q4 2024 Added 48.36%
$846M
$3.25 Million 2.77% of portfolio
197,000
Q2 2024 Added 13.87%
$1.39B
$2.89 Million 2.46% of portfolio
114,700
Q1 2024 Added 38.69%
$1.37B
$2.58 Million 2.2% of portfolio
148,000
Q3 2024 Added 21.31%
$9.92B
$2.53 Million 2.16% of portfolio
15,280
Q2 2022 Added 64.66%
$760M
$2.45 Million 2.09% of portfolio
72,910
Q3 2024 Reduced 51.39%
$309M
$2.32 Million 1.98% of portfolio
210,000
Q1 2024 Added 147.06%
$11.1B
$2.11 Million 1.8% of portfolio
52,200
Q3 2024 Reduced 29.65%
$570M
$2.08 Million 1.77% of portfolio
78,000
Q4 2024 Added 34.48%
$13.5M
$1.78 Million 1.52% of portfolio
1,225,489
Q4 2024 Reduced 7.25%
$17.7B
$1.6 Million 1.36% of portfolio
34,619
Q3 2024 New
$202M
$1.47 Million 1.25% of portfolio
310,930
Q4 2024 Reduced 3.12%
$5.64B
$1.44 Million 1.23% of portfolio
50,000
Q2 2021 Added 42.86%
$495M
$1.2 Million 1.02% of portfolio
161,350
Q4 2024 Added 136.06%
$2B
$923,000 0.79% of portfolio
31,000
Q4 2024 Added 55.0%
$1.02B
$718,000 0.61% of portfolio
50,000
Q4 2024 Added 66.67%
$3.01B
$673,000 0.57% of portfolio
16,000
Q4 2024 New
$917M
$597,000 0.51% of portfolio
26,000
Q4 2024 Added 111.38%
$699M
$593,000 0.51% of portfolio
30,000
Q3 2021 Added 50.0%
$280M
$567,000 0.48% of portfolio
67,000
Q4 2024 Reduced 18.29%
$1.31B
$532,000 0.45% of portfolio
58,000
Q4 2024 Reduced 70.71%
$259M
$520,000 0.44% of portfolio
60,000
Q4 2024 New
$918M
$494,000 0.42% of portfolio
40,000
Q1 2024 New
$8.24B
$478,000 0.41% of portfolio
10,000
Q4 2022 New
$4.33B
$470,000 0.4% of portfolio
10,000
Q1 2024 Reduced 60.0%
$2.76B
$446,000 0.38% of portfolio
14,000
Q2 2024 Reduced 22.22%
$9.35B
$425,000 0.36% of portfolio
3,500
Q4 2024 Added 40.0%
$35M
$409,000 0.35% of portfolio
368,766
Q4 2024 Added 3,587.66%
$2.3B
$392,000 0.33% of portfolio
10,000
Q2 2022 New
$46.9M
$377,000 0.32% of portfolio
125,000
Q4 2024 New
$107M
$370,000 0.32% of portfolio
325,239
Q1 2024 Added 44.4%
$3.6B
$361,000 0.31% of portfolio
10,000
Q1 2024 New
$321M
$346,000 0.3% of portfolio
51,000
Q4 2024 New
$614M
$353,000 0.3% of portfolio
20,000
Q3 2024 New
$5.47B
$338,000 0.29% of portfolio
4,000
Q1 2024 New
$2B
$345,000 0.29% of portfolio
8,000
Q4 2024 New
$1.6B
$300,000 0.26% of portfolio
40,000
Q2 2024 Added 100.0%
$942M
$287,000 0.25% of portfolio
15,000
Q1 2020 Reduced 50.0%
$634M
$285,000 0.24% of portfolio
419,832
Q4 2024 Reduced 10.64%
$2.66B
$275,000 0.23% of portfolio
7,365
Q1 2024 New
$2.66B
$263,000 0.22% of portfolio
28,000
Q4 2022 Reduced 26.32%
$387M
$243,000 0.21% of portfolio
20,000
Q2 2024 Reduced 20.36%

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $117 Million
  • Prior Value $108 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 10 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email